Viatris Inc. 首席执行官在近期电话会议中透露，公司已于去年11月与美国食品药品监督管理局（FDA）会面，专题汇报印度印多尔工厂的整改进展。首席执行官明确表示，该工厂将在今年内全面准备就绪，以迎接FDA的再次现场检查，但具体复查时间安排仍取决于监管机构的日程规划。
Viatris Inc. 首席执行官在近期电话会议中透露，公司已于去年11月与美国食品药品监督管理局（FDA）会面，专题汇报印度印多尔工厂的整改进展。首席执行官明确表示，该工厂将在今年内全面准备就绪，以迎接FDA的再次现场检查，但具体复查时间安排仍取决于监管机构的日程规划。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.